Exterior of the Ministry of Health.
The Ministry of Health published this Monday the agreements established by the Interministerial Commission on Drug Prices (CIPM) at their meeting on April 4. On this occasion, he has given the green light to include in the public financing of the National Health System (SNS) six new drugs, while it has agreed not to finance four drugs. In addition, he has approved six new drug indications, including Gilead’s anticovid drug remdesivir.
under the trade name Veklury, this medicine is already financed in Spain for the covid-19 treatment in adults and adolescents with pneumonia requiring supplemental oxygen (high or low flow oxygen or other
non-invasive ventilation at the start of treatment). With this new CIPM approval, its funded indication is extended to adults who do not require supplemental oxygen and that they are at risk of becoming serious.
On the other hand, in the document published by Health, a ‘gazapo’ appears. And it is that in the section of allegations, there is a text in Red color written in the first person proposing to the General Directorate of Pharmacy of the Ministry remove a proposal for a reduced contribution for one of the medicines, specifically Gastrofrenal (Alfasigma).
— We are expanding the information—
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Medical Writing is edited and prepared by journalists. We recommend the reader that any questions related to health be consulted with a health professional.
